Sponsor Dossier
Amgen
Sponsor Dossier for Amgen. ARTG portfolio, PBS-listed brands, PBAC activity, AusPAR record — compiled by arcimedes.
- Brand: AJEMNYE
- Brand: AMGEVITA
- Brand: ARANESP
- Brand: BLINCYTO
- Brand: CORORA
- Brand: DEPTARGIS
- Brand: EVENITY
- Brand: GANVADO
- Device (sponsor): Subcutaneous/intramuscular injection set, medicated
About
Amgen is an Australian Private Company with ABN 31051057428, registered in NSW and currently active.
Portfolio
Amgen has 24 brands on the ARTG, of which 20 are indexable. The portfolio includes 18 brands with Product Information on file, 11 brands with at least one PBS-listed item, 16 brands with PBAC outcomes on record, and 11 brands with AusPARs on record.
Therapeutic focus —
Oncology: 14 brands — Immunology: 4 brands — Neurology: 2 brands — Endocrinology: 2 brands — Haematology: 1 brand — Infectious Disease: 1 brand
PBS footprint
Amgen has 11 brands with at least one PBS-listed item, with the portfolio most recently touching the PBS schedule on 2026-05-01.
Regulatory activity
Amgen's latest PBAC outcome is dated 2025-12-01, with 16 brands holding PBAC outcomes on record. The latest AusPAR is dated 2025-06-04, with 11 brands holding AusPARs on record.